期刊文献+
共找到231篇文章
< 1 2 12 >
每页显示 20 50 100
Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma 被引量:12
1
作者 Xiao Feng Huang Chun Mei Wang +5 位作者 Xiao Wen Dai Zhen Jiang Li Bo Rong Pan Li Bin Yu Bin Qian Li Fang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期693-698,共6页
AIM To determine the expression and clinicalsignificance of chromogranin A and cathepsin Din hepatocellular carcinoma(HCC).METHODS Double immunofluorescence stain-ing techniques combined with laser confocalscanning mi... AIM To determine the expression and clinicalsignificance of chromogranin A and cathepsin Din hepatocellular carcinoma(HCC).METHODS Double immunofluorescence stain-ing techniques combined with laser confocalscanning microscopy(LSCM)was used toinvestigate chromogranin A and cathepsin Dexpressions in 85 HCC patients.RESULTS Cathepsin D was expressed in :3normal liver tissues,while in HCC the stainingshowed regional variation and the fraction ofstrongly stained cells increased as the tumorsbecame less differentiated and usually clinicallymore malignant.Cells which showed strongpositivity for cathepsin D were present in 71/85(83.5%)cases.Strong expression of cathepsinD in cancer cells was related tohistopathological features.They were morecommon in grade 3-4(26/28,92.9%)and grade2(46/53,86.8%)tumors than in grade 1 tumors(1/4,25.0%)(P【0.01).No significantcorrelation was found between age andcathepsin D expression.In patients with positivecathepsin D reaction,the mean age was 52.1±2.8 years(range 32-68 years)and in the groupwith negative reaction,the mean age was 51.3±4.5 years(range 28-71 years).No obvious relationship was observed between CgAexpression in cancer cells and thehistopathological features.The CgA positiverate was 75.0%(3/4)in grade 1,71.7%(38/53)in grade 2,and 71.4%(20/28)in grade 3-4(P】0.05)tumors.The coexpression of CgA andcathepsin D was found by double labeledimmunofluorescence staining techniques.Theprocessing of cathepsin D was disturbed in HCCcells and accumulated in the cells.Cathepsin Dhad proteolytic activity and autocrine mitogeniceffect,suggesting their functions in invasion.These findings demonstrated that the expressionof cathepsin D in HCC had prognostic value.CONCLUSION Chromogranin A and cathepsin Dare expressed in a high proportion of HCC andthe existence of cathepsin D in HCC might berelated to processing of CgA.This is clearly asubject for further studies because of itspotential clinical applications. 展开更多
关键词 carcinoma hepatocellular/pathology CATHEPSIN D/metabolism chromogranins/metabolism microscopy CONFOCAL
暂未订购
Qinghua decoction(清化饮)improves chronic nonbacterial prostatitis possibly via regulating the chromogranin A/nerve growth factor/tyrosine kinase A signaling pathway mediated by inflammatory factors 被引量:3
2
作者 HAN Yunpeng YU Wentao +3 位作者 ZHANG Ying XU Huazhou DENG Guoxing FANG Chaoyi 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2023年第4期695-703,共9页
OBJECTIVE:To explore the mechanism by which Qinghua decoction(清化饮)regulates neuroendocrine inflammation in chronic nonbacterial prostatitis(CNP)model rats and provide an experimental basis for clinical treatment.ME... OBJECTIVE:To explore the mechanism by which Qinghua decoction(清化饮)regulates neuroendocrine inflammation in chronic nonbacterial prostatitis(CNP)model rats and provide an experimental basis for clinical treatment.METHODS:The rats were randomly divided into six groups:normal control,model,Qianlie Tongyu capsule,low-dose Qinghua decoction,medium-dose Qinghua decoction,and high-dose Qinghua decoction group with six rats in each group.Rats in each group were sacrificed on the 29th day of treatment,and blood and prostate tissues were collected.Serum levels of tumor necrosis factor-alpha and interleukins 1-beta,6,8,and 10(TNF-αand IL-1β,-6,-8,and-10,respectively)were measured using enzyme-linked immunosorbent assay.The pathological changes in the rat prostate tissue in each group were observed under a light microscope.The expression levels of chromogranin A(CgA),nerve growth factor(NGF),and tyrosine kinase A(TrkA)were detected using reverse transcription quantitative polymerase chain reaction.Western blotting was used to detect protein expression of CgA,NGF,and TrkA.RESULTS:In the model group,the prostate capsule membrane and stroma were significantly dilated with more inflammatory cells infiltrating the stroma and perivessels.TNF-α,IL-1β,-6,and-8,CgA,NGF,and TrkA levels increased,whereas the content of IL-10 decreased,which was statistically significant compared to that in the normal control group(P<0.05).Prostate tissue cells in the high-dose group were neatly arranged with no obvious inflammatory cell infiltration.When compared with the model group,the high-dose Qinghua decoction group showed a significant improvement in these indices(P<0.05).CONCLUSION:Qinghua decoction led to inhibition of pathological changes in the prostate tissue of rats with CNP,regulation of inflammatory cytokine expression,and inhibition in the expression of CgA,NGF,and TrkA.This mechanism may be primarily related to regulation of the CgA/NGF/TrkA signaling pathway mediated by various inflammatory factors. 展开更多
关键词 inflammation INTERLEUKINS chromogranin A nerve growth factor chronic nonbacterial prostatitis Qinghua decoction
原文传递
Prognostic role of chromogranin A in :astration-resistant prostate cancer: a meta-analysis 被引量:1
3
作者 Peng Hong Run-Qi Guo +5 位作者 Gang Song Kai-Wei Yang Lei Zhang Xue-Song Li Kai Zhang Li-Qun Zhou 《Asian Journal of Andrology》 SCIE CAS CSCD 2018年第6期561-566,共6页
We aimed to investigate the prognostic value of chromogranin A (CgA) in castration-resistant prostate cancer (CRPC). We conducted a systematic literature search of PubMed, Web of Science, and EMBASE for citations ... We aimed to investigate the prognostic value of chromogranin A (CgA) in castration-resistant prostate cancer (CRPC). We conducted a systematic literature search of PubMed, Web of Science, and EMBASE for citations published prior to September 2017 that described CgA and CRPC and performed a standard meta-analysis on survival outcomes. Our meta-analysis included eight eligible studies with 686 patients. The results were as follows: progression-free survival (PFS) was associated with CgA level (hazard ratio [HR] = 2.47, 95% confidence interval [CI]: 1.47-4.14, P = 0.0006); PFS was relative to CgA change (HR = 9.22, 95% Ch 3.03-28.05, P〈 0.0001); and overall survival (OS) was relative to CgA level (HR = 1.47, 95% Ch 1.15-1.87, P= 0.002). When we divided the patients into two groups according to therapy status, the result for OS relative to CgA level was an HR of 1.26 (95% CI: 1.09-1.45, P = 0.001) in the first-line hormonal therapy group, and an HR of 2.33 (95% Ch 1.40-3.89, P = 0.001) in the second-line hormonal therapy or chemotherapy group. This meta-analysis indicated that a high CgA level had a negative influence on OS and PFS in CRPC patients. In addition, CRPC patients with a rising CgA had a shorter PFS. Further studies are needed to verify the prognostic value of CgA in CRPC. 展开更多
关键词 castration-resistant prostate cancer chromogranin A PROGNOSIS
原文传递
Salivary levels of cortisol and chromogranin A in patients with burning mouth syndrome: A case-control study
4
作者 Chieko Shigeyama-Haruna Inho Soh +3 位作者 Akihiro Yoshida Shuji Awano Hisashi Anan Toshihiro Ansai 《Open Journal of Stomatology》 2013年第1期39-43,共5页
Burning mouth syndrome (BMS) is a poorly understood oral pain disorder characterized by a painful burning sensation in the oral cavity without any mucosal abnormalities. In this study, we evaluated the salivary cortis... Burning mouth syndrome (BMS) is a poorly understood oral pain disorder characterized by a painful burning sensation in the oral cavity without any mucosal abnormalities. In this study, we evaluated the salivary cortisol and chromogranin A (CgA) levels of patients with BMS in comparison with age-matched controls. Subjects (n = 114) included 81 BMS patients and 33 controls. Patients with BMS were further classified into a subgroup of subjects who occasionally feel a burning sensation (BMS 1), and a subgroup of subjects who always feel a burning sensation (BMS 2). Salivary cortisol and CgA levels were measured using ELISA kits. All individuals with BMS had significantly higher cortisol and CgA levels than the controls did. Furthermore, when comparing the controls with each BMS subgroup, salivary levels of cortisol were significantly higher in both subgroups than controls. In contrast, the level of CgA was significantly higher in the BMS 2 subgroup only. Multiple regression analysis revealed a significant independent association between salivary levels of cortisol and BMS even after adjustment for gender, antidepressant or antianxiety drug use and hypertension (drug-treated). The study revealed that a significant association was observed between salivary cortisol levels and BMS. 展开更多
关键词 BURNING MOUTH Syndrome CORTISOL chromogranin A
暂未订购
Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
5
作者 Stavros Gkolfinopoulos Konstantinos Tsapakidis +2 位作者 Konstantinos Papadimitriou Demetris Papamichael Panteleimon Kountourakis 《World Journal of Methodology》 2017年第1期9-15,共7页
Chromogranin A, due to its primary expression throughout the neuroendocrine system, is a widely accepted biomarker for the assessment of neuro-endocrine tumors. It has been traditionally used in the management of pati... Chromogranin A, due to its primary expression throughout the neuroendocrine system, is a widely accepted biomarker for the assessment of neuro-endocrine tumors. It has been traditionally used in the management of patients with tumors of gastro-enteropancreatic origin. Lately, it has also been implicated in various conditions and diseases, both benign and malignant. However, the paucity of data of adequate strength, as well as its relation with common physiologic conditions and its interaction with commonly prescribed medications, limit its clinical use in only a narrow spectrum. Herein, we present a thorough review to the most frequent conditions where its levels are affected, focusing specifically on its potential use as a prognostic and predictive biomarker in oncology. 展开更多
关键词 CANCER Neuroendocrine tumors PROGNOSIS chromogranin A BIOMARKER
在线阅读 下载PDF
Combination of insulin-like growth factor-1, IGF binding protein-3, chromogranin A and prostate specific antigen can improve the detection of prostate cancer 被引量:1
6
作者 Saleh Ahmed Kamaleldin Saleh Heba Mohamed Adly Anmar Mohammed Nassir 《Journal of Cancer Metastasis and Treatment》 CAS 2017年第1期82-89,共8页
Aim:Prostate cancer(PCa)is the second most prevalent male cancer worldwide and designated the sixth most frequent male cancer in Arab countries.Although prostate specific antigen(PSA)has become the best and most valua... Aim:Prostate cancer(PCa)is the second most prevalent male cancer worldwide and designated the sixth most frequent male cancer in Arab countries.Although prostate specific antigen(PSA)has become the best and most valuable biomarker for screening of PCa,elevated levels of PSA can reflect the presence of malignant cells but can overlap with benign prostatic diseases.There is a necessity to develop and improve current tools for early detection and diagnosis of PCa.This study was done to evaluate the validation of serum insulin-like growth factor-1(IGF-1),IGF binding protein-3(IGFBP-3),chromogranin A(CgA)and combination with PSA in treatment of benign prostatic hyperplasia(BPH)and PCa patients.Methods:The study included 72 patients with PCa,70 BPH patients and 56 healthy male subjects of matched age.Full history and clinical data were recorded for all subjects.Results:Serum PSA attained sensitivity of 84%at 82%specificity with an accuracy of 83%,although IGF-1,IGFBP-3 and CgA did not recognize PCa patients.Conclusion:Combinations of IGF-1 and IGFBP-3 biomarkers with PSA were effectively differentiated between PCa and control groups as well as improving the overall value of sensitivity,specificity and diagnostic accuracy of PCa to 85%and 86%for IGF-1/PSA and IGFP-3/PSA respectively. 展开更多
关键词 Prostate cancer benign prostatic hyperplasia insulin-like growth factor-1 IGF binding protein-3 chromogranin A
原文传递
Mutual relationships between contents of chromogranin A, cholecys-tokinin octapeptide and serotonin in individual EC cells
7
作者 王瑞安 蔡文琴 +2 位作者 张成岗 M.Stridsberg 苏慧慈 《Chinese Science Bulletin》 SCIE EI CAS 1995年第5期417-421,共5页
Chromogranin A (CgA) is a kind of acidic protein originally isolated from the chromaffin cells of the ox adrenal gland medulla. It was found that the CgA was also widely distributed in the neuroendocrine cells besides... Chromogranin A (CgA) is a kind of acidic protein originally isolated from the chromaffin cells of the ox adrenal gland medulla. It was found that the CgA was also widely distributed in the neuroendocrine cells besides the adrenal medulla. The physiological function of the CgA is not yet elucidated, but it was presumed to be involved in organizing the granule matrix and regulating the processing of the prohormones. Besides, CgA is also the precursor of some peptide hormones such 展开更多
关键词 chromogranin A CHOLECYSTOKININ 5-HYDROXYTRYPTAMINE EC cells.
在线阅读 下载PDF
子宫内膜癌组织CGA、CK7、NapsinA水平及与患者临床病理特征、预后的关系
8
作者 马旭漫 史晓丝 +2 位作者 石焱 高艳民 成亚亚 《国际检验医学杂志》 2026年第2期178-185,共8页
目的探究子宫内膜癌组织嗜铬粒蛋白A(CGA)、细胞角蛋白7(CK7)、天门冬氨酸蛋白酶A(NapsinA)水平及与患者临床病理特征、预后的关系。方法选取2017年5月至2021年5月保定市妇幼保健院收治的141例子宫内膜癌患者为研究对象,根据术后3年是... 目的探究子宫内膜癌组织嗜铬粒蛋白A(CGA)、细胞角蛋白7(CK7)、天门冬氨酸蛋白酶A(NapsinA)水平及与患者临床病理特征、预后的关系。方法选取2017年5月至2021年5月保定市妇幼保健院收治的141例子宫内膜癌患者为研究对象,根据术后3年是否生存分为预后良好组(n=106)和预后不良组(n=35)。采用实时荧光定量PCR(qPCR)、免疫组化法检测子宫内膜癌组织及癌旁组织中CGA、CK7、NapsinA mRNA、蛋白表达水平。采用Spearman法分析CGA、CK7、NapsinA mRNA表达与患者临床病理特征的相关性。采用多因素Logistic回归分析患者预后不良的影响因素。绘制受试者工作特征(ROC)曲线分析癌组织CGA、CK7、NapsinA表达对子宫内膜癌患者预后不良的预测价值。结果与癌旁组织相比,子宫内膜癌组织CGA、CK7、Napsin mRNA表达水平均增加(P<0.05)。CGA、CK7、NapsinA表达在不同国际妇产科联盟(FIGO)分期、肿瘤分化程度、浸润深度和淋巴结转移情况患者中差异有统计学意义(P<0.05)。癌组织CGA、CK7、NapsinA水平与患者FIGO分期、浸润深度和淋巴结转移呈正相关(P<0.05),与肿瘤分化程度呈负相关(P<0.05)。与预后良好组相比,预后不良组CGA、CK7、NapsinA水平均升高(P<0.05)。癌组织CGA、CK7、NapsinA均为子宫内膜癌患者预后不良的危险因素(P<0.05)。癌组织CGA、CK7、NapsinA表达预测子宫内膜癌患者预后不良的曲线下面积分别为0.874、0.873、0.882,三者联合预测的曲线下面积为0.963,显著大于CGA(Z=2.180,P=0.029)、CK7(Z=2.205,P=0.027)、NapsinA(Z=1.984,P=0.047)单独预测。结论子宫内膜癌组织CGA、CK7、NapsinA呈高表达,与患者FIGO分期、肿瘤分化程度、浸润深度、淋巴结转移相关,三者联合具有较高的预后不良预测价值。 展开更多
关键词 子宫内膜癌 嗜铬粒蛋白A 细胞角蛋白7 天门冬氨酸蛋白酶A
暂未订购
具有神经内分泌免疫组织化学特征的胃肝样腺癌的临床病理分析
9
作者 杜明占 石伟强 郭霞 《临床与病理杂志》 2025年第7期807-816,共10页
目的:胃肝样腺癌(hepatoid adenocarcinoma of the stomach,HAS)是一种罕见的胃癌亚型,其形态学类似肝细胞癌。部分病例可伴有神经内分泌标志物的免疫组织化学表达,其中少数病例表达显著。本研究旨在通过回顾性分析具有显著神经内分泌... 目的:胃肝样腺癌(hepatoid adenocarcinoma of the stomach,HAS)是一种罕见的胃癌亚型,其形态学类似肝细胞癌。部分病例可伴有神经内分泌标志物的免疫组织化学表达,其中少数病例表达显著。本研究旨在通过回顾性分析具有显著神经内分泌免疫组织化学特征HAS患者的临床资料,为提高此类患者的临床诊断水平提供帮助。方法:纳入苏州大学附属第一医院收治的具有显著神经内分泌免疫组织化学特征的HAS患者。患者均具有典型的HAS病理特征,且至少表达神经内分泌免疫组织化学指标突触素(synaptophysin,Syn)和嗜铬粒蛋白A(chromogranin A,CgA)中的1种。对患者的一般临床资料,以及肿瘤组织的大体形态、HE染色结果、免疫组织化学染色结果进行回顾性分析。结果:纳入患者13例,其中男11例,女2例,年龄55~79(67.9±8.8)岁。患者血清甲胎蛋白(alpha fetoprotein,AFP)水平为14.73~902.54μg/L。肿瘤部位:贲门5例,胃底2例,胃角2例,胃窦4例。肿瘤最大径2.5~10.0 cm,切面呈灰白色。1例为隆起型(Borrman I型),12例为溃疡型(Borrman Ⅲ型)。肿瘤细胞部分呈弥漫、片状分布,部分呈结节状分布,间质血窦丰富。细胞呈多边形,体积中等或偏大,细胞质呈嗜酸性、嗜碱性或透明,核分裂象易见,部分管腔内或细胞内可见嗜伊红物质。在13例HAS患者中,婆罗双树样基因4(spalt-like transcription factor 4,SALL4)阳性11例,AFP阳性6例,磷脂酰肌醇蛋白聚糖3(glypican-3,GPC3)阳性4例,Syn阳性13例,CgA阳性12例,CD56阳性7例,胰岛素瘤相关蛋白1(insulinoma-associated protein 1,INSM1)阳性7例,细胞角蛋白(cytokeratin,CK)7阳性4例。Ki-67增殖指数为60%~90%。人表皮生长因子受体-2(human epidermal growth factor receptor 2,HER-2)表达为0的有9例,1+的有4例。1例患者接受术前新辅助化疗和术后化疗,8例只接受了术后化疗,4例未进行化疗。随访时间3~57个月,7例患者因肿瘤死亡,6例存活。结论:HAS可表现为显著的神经内分泌免疫组织化学特征,预后较差。明确HAS可具有显著神经内分泌免疫组织化学特征,有助于加深对此类肿瘤的认识,减少误诊、漏诊的发生。 展开更多
关键词 胃肝样腺癌 神经内分泌 免疫组织化学特征 突触素 嗜铬粒蛋白A
暂未订购
Pancreatic neuroendocrine microtumors in the elderly:A retrospective study using cadaveric pancreatic tissue
10
作者 Ting Yang Ke Ren +6 位作者 Xiang-Quan Chen Taku Toriumi Yutaro Natsuyama Jun Li Aoi Sukeda Toshitaka Nagao Shuang-Qin Yi 《World Journal of Gastrointestinal Oncology》 2025年第12期137-146,共10页
BACKGROUND Pancreatic neuroendocrine microtumors(PNEMTs)are small(<5 mm),nonfunctioning,well-differentiated neuroendocrine neoplasms.Although they are rare,they are not invariably benign.PNEMTs are typically discov... BACKGROUND Pancreatic neuroendocrine microtumors(PNEMTs)are small(<5 mm),nonfunctioning,well-differentiated neuroendocrine neoplasms.Although they are rare,they are not invariably benign.PNEMTs are typically discovered incidentally during autopsy.However,data regarding the occurrence of PNEMTs in the elderly population,particularly those identified incidentally in cadaveric studies,remain limited.AIM To investigate the prevalence and histopathological characteristics of PNEMTs in elderly individuals by analyzing cadaveric pancreatic tissues.METHODS We conducted a retrospective analysis of 85 pancreatic specimens(age range:58-109 years)obtained from cadavers for anatomical education and research at the Department of Life Dentistry,Nippon Dental University.Paraffin sections of the pancreatic head,body,and tail were prepared for histological and immunohistochemical analysis.RESULTS Five cases with PNEMTs(5/85,5.9%;male,n=33;female,n=52;mean age:85.8±12.1 years)were identified.The tumors were solitary,well circumscribed,and located within the pancreatic parenchyma(body:n=4;tail:n=1),and all were<5 mm(range:0.54-2.20 mm)in size.All tumors showed strong chromogranin A and synaptophysin positivity,and were predominantly glucagon(GLU)-positive.Ki-67 immunostaining indicated minimal proliferative activity;therefore,these tumors were considered non-functioning,GLU-producing,well-differentiated grade 1 PNEMTs.CONCLUSION Small,predominantly low-grade,GLU-secreting PNEMTs were present in 5.9%of elderly individuals,highlighting the prevalence of subclinical PNEMTs and the need for careful follow-up. 展开更多
关键词 Pancreatic neuroendocrine microtumors Elderly populations Cadaveric study Well-differentiated pancreatic neuroendocrine neoplasms Non-functioning tumor chromogranin A SYNAPTOPHYSIN
暂未订购
SGLT2抑制剂通过调节NT-proBNP和CgA水平对心力衰竭患者心血管获益的影响
11
作者 祁瑞哲 郭炜亚 +3 位作者 赵爱军 赵瑞云 霍丽颖 赵新超 《中国分子心脏病学杂志》 2025年第4期6957-6961,共5页
目的探讨SGLT2抑制剂通过调节NT-proBNP和CgA水平对心力衰竭(heart failure,HF)患者心血管获益的影响。方法选取2022年1月至2023年12月本院收治的150例HF患者为研究对象,随机分为对照组和钠-葡萄糖协同转运蛋白2(sodium-glucose cotrans... 目的探讨SGLT2抑制剂通过调节NT-proBNP和CgA水平对心力衰竭(heart failure,HF)患者心血管获益的影响。方法选取2022年1月至2023年12月本院收治的150例HF患者为研究对象,随机分为对照组和钠-葡萄糖协同转运蛋白2(sodium-glucose cotransporter 2,SGLT2)组,每组75例。对照组采取常规治疗,SGLT2抑制剂组在此基础联合使用SGLT2抑制剂治疗。比较两组治疗总有效率、血浆N端脑钠肽前体(N-terminal pro-brain natriuretic peptide,NT-proBNP)、嗜铬粒蛋白A(chromogranin A,CgA)水平、心室功能、出院3个月后再住院率及不良反应发生情况。结果SGLT2抑制剂组治疗总有效率、左室射血分数(left ventricular ejection fraction,LVEF)高于对照组,差异有统计学意义(P<0.05);血清NT-proBNP和CgA水平、左室舒张末期内径(left ventricular end-diastolic dimension,LVEDD)低于对照组,差异有统计学意义(P<0.05)。两组低血压、肾功能恶化以及高血钾症等不良反应发生情况比较,差异无统计学意义(P>0.05),SGLT2抑制剂组出院3个月后再住院率低于对照组,差异有统计学意义(P<0.05)。结论SGLT2抑制剂可通过调节NT-proBNP和CgA水平改善HF患者心血管健康及心室功能,从而提高治疗有效率、降低再次入院的风险。 展开更多
关键词 钠-葡萄糖协同转运蛋白2 氨基末端脑利钠肽前体 嗜铬粒蛋白A 心力衰竭
原文传递
CT增强扫描联合血清CgA水平对胃肠道神经内分泌肿瘤鉴别诊断及病理分级评估的临床价值
12
作者 张宪辉 司远 +2 位作者 齐康达 杨家伟 郝瑞朝 《医学影像学杂志》 2025年第6期71-76,86,共7页
目的探讨CT增强扫描联合血清嗜铬粒蛋白A(CgA)水平对胃肠道神经内分泌肿瘤(GINEN)鉴别诊断及病理分级评估的临床价值。方法选取GINEN患者70例(GINEN组),根据细胞增殖活性和核分裂象分为G1、G2级28例及G3级42例,同期另选取胃肠道淋巴瘤(P... 目的探讨CT增强扫描联合血清嗜铬粒蛋白A(CgA)水平对胃肠道神经内分泌肿瘤(GINEN)鉴别诊断及病理分级评估的临床价值。方法选取GINEN患者70例(GINEN组),根据细胞增殖活性和核分裂象分为G1、G2级28例及G3级42例,同期另选取胃肠道淋巴瘤(PGIL)患者30例(PGIL组),所有患者于术前接受CT增强扫描及血清CgA检测。比较两组CT增强扫描特征及血清CgA水平,采用受试者工作特征(ROC)曲线分析CT增强扫描特征及血清CgA水平对GINEN的鉴别诊断价值;比较不同病理分级GINEN患者CT增强扫描特征及血清CgA水平,采用ROC曲线分析CT增强扫描特征及血清CgA水平对GINEN病理分级评估的临床价值。结果两组CT增强扫描特征中的病变大小、数目、强化均匀度及血清CgA水平比较,差异均有统计学意义(P均<0.05);ROC曲线分析显示CT增强扫描特征联合血清CgA水平鉴别诊断GINEN的曲线下面积(AUC)显著高于CT增强扫描特征及血清CgA水平单独鉴别诊断GINEN的AUC(P均<0.05)。G1、G2级GINEN患者CT增强扫描特征中的病变形态浸润型占比、病变大小≥6.5 cm^(2)占比,有囊变、溃疡或坏死占比及有淋巴结转移占比和血清CgA水平均低于G3级GINEN患者(P均<0.05);ROC曲线分析显示CT增强扫描特征联合血清CgA水平评估GINEN病理分级3级的AUC显著高于CT增强扫描特征及血清CgA水平单独评估GINEN病理分级3级的AUC(P均<0.05)。结论CT增强扫描和血清CgA水平对GINEN诊断及病理分级评估均有一定临床价值,二者联合能够提高对GINEN鉴别诊断及病理分级评估的临床价值。 展开更多
关键词 体层摄影术 X线计算机 嗜铬粒蛋白A 胃肠道神经内分泌肿瘤 鉴别诊断 病理分级
暂未订购
沙库巴曲缬沙坦钠对扩张型心肌病心衰患者NT-proBNP、CgA水平及心功能指标的影响研究
13
作者 邝光华 周宇明 《中国实用医药》 2025年第1期1-5,共5页
目的研究扩张型心肌病(DCM)心力衰竭(心衰,HF)患者使用沙库巴曲缬沙坦钠治疗后对氨基末端B型利钠肽前体(NT-proBNP)、嗜铬粒蛋白A(CgA)和心功能指标的影响。方法选取60例DCM心衰患者作为观察组,根据随机双盲法将观察组患者分为A组与B组,... 目的研究扩张型心肌病(DCM)心力衰竭(心衰,HF)患者使用沙库巴曲缬沙坦钠治疗后对氨基末端B型利钠肽前体(NT-proBNP)、嗜铬粒蛋白A(CgA)和心功能指标的影响。方法选取60例DCM心衰患者作为观察组,根据随机双盲法将观察组患者分为A组与B组,各30例;另选取同期30例健康体检者作为对照组。对照组不进行任何治疗,观察组给予利尿剂、强心剂和硝酸酯类等常规药物治疗,在此基础上A组行培哚普利治疗,B组行沙库巴曲缬沙坦钠治疗。比较观察组与对照组、A组与B组的临床基本资料,观察组治疗前与对照组的CgA、NT-proBNP水平,A组与B组治疗前后的血清指标(CgA和NT-proBNP)和心功能指标[左室射血分数(LVEF)、左室收缩末期容积(LVESV)和左室舒张末期容积(LVEDV)]。结果观察组与对照组、A组与B组的年龄、性别、体质量指数(BMI)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、空腹血糖(FPG)、收缩压、舒张压比较差异无统计学意义(P>0.05)。对照组CgA、NT-proBNP水平低于观察组及观察组美国纽约心脏病学会(NYHA)分级Ⅱ、Ⅲ、Ⅳ级患者(P<0.05);观察组NYHA分级Ⅳ级患者CgA、NT-proBNP水平高于Ⅲ、Ⅱ级患者,且NYHA分级Ⅲ级患者CgA、NT-proBNP水平高于Ⅱ级患者(P<0.05)。治疗后,A组的LVEF(31.49±2.52)%明显低于B组的(33.79±3.11)%(P<0.05);B组的NT-proBNP(1534.20±1249.31)pg/ml、CgA(164.20±76.57)ng/ml、LVEDV(159.23±23.75)ml和LVESV(109.06±14.84)ml均明显低于A组的(2139.35±1032.66)pg/ml、(213.10±100.17)ng/ml、(176.52±38.17)ml、(129.26±27.68)ml(P<0.05)。观察组NT-proBNP与LVESV、LVEDV呈正相关(r=0.701、0.706,P<0.01),与LVEF呈负相关(r=-0.390,P<0.01);CgA与LVEF呈负相关(r=-0.649,P<0.01),与LVESV和LVEDV呈正相关(r=0.569、0.585,P<0.01);NT-proBNP与CgA呈正相关(r=0.602,P<0.01)。结论DCM心衰患者使用沙库巴曲缬沙坦钠治疗可有效改善心功能和降低CgA水平的表达,值得临床推广使用。 展开更多
关键词 沙库巴曲缬沙坦钠 扩张型心肌病 心力衰竭 氨基末端B型利钠肽前体 嗜铬粒蛋白A 心功能指标 左室射血分数
暂未订购
CGA 衍生多肽 CHR 抑制 TNF -α引起的血管内皮细胞高通透性的研究 被引量:3
14
作者 古妮娜 张丹 +4 位作者 罗丽 陈晓迎 谢明 刘景仑 姜丽萍 《中国急救医学》 CAS CSCD 北大核心 2014年第8期747-751,共5页
目的:观察嗜铬粒蛋白 A ( chromogranin A , CGA )的衍生多肽 CGA47-66(chromogranin, CHR)对TNF-α引起血管内皮细胞(EA.hy926)高通透性的影响和初步机制。方法分别用 CHR、TNF -α作用人血管内皮细胞系 EA.hy926,应用 Tra... 目的:观察嗜铬粒蛋白 A ( chromogranin A , CGA )的衍生多肽 CGA47-66(chromogranin, CHR)对TNF-α引起血管内皮细胞(EA.hy926)高通透性的影响和初步机制。方法分别用 CHR、TNF -α作用人血管内皮细胞系 EA.hy926,应用 Transwell 小室法、PCR、Western-blot检测单层内皮细胞通透性的改变,血管内皮钙黏蛋白VE-cadherin mRNA和蛋白的表达,以及磷酸化p38丝裂素活化蛋白激酶( p38 mitogen activated protien kinase , p38 MAPK)和总p38 MAPK等渗透性相关蛋白的表达。结果与空白对照组比较,TNF-α组EA.hy926细胞的通透性显著增高(2.479±0.117比1.769±0.554,t=3.543,P=0.008),VE-cadherin mRNA的表达显著降低(1.145±0.035比1.593±0.161, t=-4.707, P=0.035),而CHR (1 nM、10 nM、100 nM)组中EA.hy926细胞的VE-cadherin mRNA的表达较空白对照组有显著增加(1.512±0.04、1.615±0.170、1.918±0.355比1.162±0.189,P<0.05),同时CHR(1 nM、10 nM、100 nM、1000 nM)能够缓解TNF-α组引起的高渗透性改变(1.954±0.379、1.835±0.090、1.430±0.349、1.559±0.447比2.479±0.117,P<0.05)和 VE -cadherin mRNA 的低表达(1.541±0.149、1.529±0.098、2.087±0.437、1.640±0.160比1.145±0.035,P<0.05),并且在1~100 nM范围内,上述作用呈剂量依赖性;Western-blot检测到TNF-α组EA.hy926细胞的VE-cadherin蛋白表达明显低于空白对照组,磷酸化p38 MAPK蛋白表达明显高于空白对照组;TNF-α组+CHR组与TNF-α组相比,TNF-α组+CHR组中VE -cadherin 蛋白的表达明显增加,磷酸化p38 MAPK蛋白明显降低。结论 CGA衍生多肽CHR能改善TNF-α引起的血管内皮细胞高通透性,这一作用在一定剂量范围内呈剂量依赖性,并且可能与p38 MAPK信号通路相关。 展开更多
关键词 嗜铬粒蛋白A(CGA) 衍生多肽CGA47-66 (CHR) 肿瘤坏死因子-α(TNF-α) 血管内皮细胞(EA hy926) 通透性 chromogranin (CGA) Chromofungin (CHR) TNF-Α Vascular endothelial cells (EA hy926)
暂未订购
益气养荣汤联合针灸对乳腺癌术后气血两虚证T淋巴细胞亚群及血清CGA、slCAM-1、GDF3水平的影响
15
作者 闫明 任璐璐 任士珂 《中华中医药学刊》 北大核心 2025年第10期243-246,共4页
目的 研究益气养荣汤联合针灸对乳腺癌术后气血两虚证患者T淋巴细胞亚群及血清嗜铬粒蛋白A(granin A,CGA)、可溶性细胞间黏附因子-1(soluble intercellular adhesion factor-1,slCAM-1)、人生长分化因子3(human growth differentiation ... 目的 研究益气养荣汤联合针灸对乳腺癌术后气血两虚证患者T淋巴细胞亚群及血清嗜铬粒蛋白A(granin A,CGA)、可溶性细胞间黏附因子-1(soluble intercellular adhesion factor-1,slCAM-1)、人生长分化因子3(human growth differentiation factor 3,GDF3)水平的影响。方法 乳腺癌术后气血两虚证患者92例均由2020年5月-2023年5月于医院接受治疗,采用随机数字表法分为对照组与试验组,各46例。对照组予以CEF方案化疗治疗,试验组在CEF方案化疗的基础上予以益气养荣汤联合针灸治疗,21 d为1个周期,共治疗4个周期。比较两组治疗前、治疗4个周期后生命质量、血清CGA、slCAM-1、GDF3水平、T淋巴细胞亚群及治疗4个周期后疗效,治疗期间不良反应发生情况。结果 较治疗前,治疗4个周期后两组功能维度、总体生命质量评分升高,且试验组更高(P<0.05)。与治疗前比较,治疗4个周期后症状维度评分及血清CGA、slCAM-1、GDF3水平降低,且试验组更低(P<0.05)。与治疗前比较,治疗4个周期后两组均降低,且试验组更低(P<0.05)。与治疗前比较,治疗4个周期后试验组全血CD4^(+)、CD4^(+)/CD8^(+)水平升高,对照组全血CD4^(+)、CD4^(+)/CD8^(+)水平降低,试验组更高(P<0.05);试验组全血CD8^(+)水平降低,对照组全血CD8^(+)水平升高,试验组更低(P<0.05)。与对照组治疗4个周期后的总有效率(61.36%,27/44)比较,试验组总有效率(83.33%,35/42)更高(P<0.05)。治疗期间,两组均未因治疗出现明显不良反应而终止治疗,试验组不良反应发生率更低(P<0.05)。结论 益气养荣汤联合针灸可调节乳腺癌术后气血两虚证患者T淋巴细胞亚群水平,抑制血清CGA、slCAM-1、GDF3表达,控制癌细胞异常增殖,提高生命质量,疗效确切,降低术后化疗并发症发生风险。 展开更多
关键词 乳腺癌 气血两虚证 益气养荣汤 针灸 T淋巴细胞亚群 嗜铬粒蛋白A 可溶性细胞间黏附因子-1 人生长分化因子3
原文传递
糖尿病肾脏疾病患者血清Apelin-13、嗜铬粒蛋白A、组蛋白去乙酰化酶6水平表达与病情严重程度及预后的相关性研究
16
作者 罗雨葳 李川 秦艳玲 《临床肾脏病杂志》 2025年第8期682-687,共6页
目的探讨糖尿病肾脏疾病(diabetic kidney disease,DKD)患者血清Apelin-13、嗜铬粒蛋白A(chromogranin A,CgA)、组蛋白去乙酰化酶6(histone deacetylase 6,HDAC6)水平表达与病情严重程度及预后的相关性。方法选取北部战区总医院2020年2... 目的探讨糖尿病肾脏疾病(diabetic kidney disease,DKD)患者血清Apelin-13、嗜铬粒蛋白A(chromogranin A,CgA)、组蛋白去乙酰化酶6(histone deacetylase 6,HDAC6)水平表达与病情严重程度及预后的相关性。方法选取北部战区总医院2020年2月至2023年2月接诊的DKD患者108例为病例组,根据Mogenson分期将病例组分为早期组(n=48)、中期组(n=33)、晚期组(n=27)。另选取100例同阶段就诊的2型糖尿病患者为对照组。采用ELISA法检测血清Apelin-13、CgA和HDAC6的表达水平;多因素Logistic回归分析DKD患者预后影响因素。应用受试者工作特征曲线分析血清Apelin-13、CgA、HDAC6在DKD患者预后中的预测价值。结果病例组患者血清Apelin-13[(23.71±6.94)ng/L比(15.26±2.37)ng/L]、CgA[(4.54±0.88)μg/L比(2.96±0.52)μg/L]、HDAC6[(1.70±0.39)ng/L比(0.85±0.13)ng/L]水平高于对照组(P<0.05)。晚期组患者血清Apelin-13[(32.64±4.03)ng/L比(25.83±3.12)ng/L、(17.24±2.36)ng/L]、CgA[(5.63±0.85)μg/L比(4.78±0.62)μg/L、(3.76±0.51)μg/L]、HDAC6[(2.13±0.36)ng/L比(1.76±0.29)ng/L、(1.41±0.23)ng/L]水平均高于中期、早期组,中期组患者血清Apelin-13[(25.83±3.12)ng/L比(17.24±2.36)ng/L]、CgA[(4.78±0.62)μg/L比(3.76±0.51)μg/L]、HDAC6[(1.76±0.29)ng/L比(1.41±0.23)ng/L]水平均高于早期组(P<0.05)。预后不良组患者血清白细胞介素6(interleukin 6,IL-6)[(26.33±4.25)pg/L比(18.62±3.55)pg/L]、Apelin-13[(28.45±5.13)ng/L比(21.34±4.25)ng/L]、CgA[(5.37±1.03)μg/L比(4.12±0.71)μg/L]、HDAC6[(2.08±0.43)ng/L比(1.51±0.37)ng/L]水平显著高于预后良好组,白蛋白水平[(27.36±2.72)g/L比(32.78±3.54)g/L]低于预后良好组(P<0.05)。血清Apelin-13、CgA、HDAC6、IL-6、白蛋白是DKD患者预后的影响因素(P<0.05)。血清Apelin-13、CgA、HDAC6联合预测DKD患者预后的曲线下面积为0.949,优于各自单独诊断(Z_(三者联合-Apelin-13)=2.452、Z_(三者联合-CgA)=2.381、Z_(三者联合-HDAC6)=2.386,P=0.014、P=0.017、P=0.017),联合诊断的敏感度、特异度分别为97.22%、86.11%。结论DKD患者血清Apelin-13、CgA、HDAC6水平明显升高,且与病情严重程度及预后有着紧密联系,三者联合检测对DKD患者预后有更佳的预测价值。 展开更多
关键词 APELIN-13 嗜铬粒蛋白A 组蛋白去乙酰化酶6 糖尿病肾脏疾病 预后
暂未订购
归脾汤加逍遥散在乳腺癌改良根治术患者术后辅助治疗中的应用效果
17
作者 杨银成 李贺 +1 位作者 王玉玺 张明政 《癌症进展》 2025年第1期103-106,共4页
目的探讨归脾汤加逍遥散在乳腺癌改良根治术患者术后辅助治疗中的应用效果。方法依据治疗方案的不同将106例乳腺癌改良根治术患者分为对照组(n=51)和观察组(n=55),对照组患者接受常规术后治疗,观察组患者在对照组基础上接受归脾汤加逍... 目的探讨归脾汤加逍遥散在乳腺癌改良根治术患者术后辅助治疗中的应用效果。方法依据治疗方案的不同将106例乳腺癌改良根治术患者分为对照组(n=51)和观察组(n=55),对照组患者接受常规术后治疗,观察组患者在对照组基础上接受归脾汤加逍遥散治疗。比较两组患者的中医证候积分、癌因性疲乏程度[Piper疲乏量表(PFS)]、血清嗜铬粒蛋白A(CgA)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)水平及临床疗效。结果治疗后,两组患者主症、次症积分和总积分均低于本组治疗前,观察组患者主症、次症积分和总积分均低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者PFS各维度评分均低于本组治疗前,观察组患者PFS各维度评分均低于对照组,差异均有统计学意义(P﹤0.05)。治疗后,两组患者血清CgA、TNF-α和IL-1β水平均低于本组治疗前,观察组患者血清CgA、TNF-α和IL-1β水平均低于对照组,差异均有统计学意义(P﹤0.05)。观察组患者的治疗总有效率为89.09%,高于对照组患者的70.59%,差异有统计学意义(P﹤0.05)。结论归脾汤加逍遥散治疗乳腺癌改良根治术患者的临床疗效显著,可改善中医证候,减轻癌因性疲乏程度,降低血清CgA、TNF-α、IL-1β水平。 展开更多
关键词 归脾汤 逍遥散 乳腺癌改良根治术 癌因性疲乏 嗜铬粒蛋白A
暂未订购
17-β-雌二醇联合去势诱导的慢性非细菌性前列腺炎大鼠前列腺中CgA和NSE水平升高
18
作者 李少飞 夏红 +2 位作者 黄镭 王俊霞 梁龙 《中国组织化学与细胞化学杂志》 2025年第5期432-438,共7页
目的本研究旨在测定17-β-雌二醇联合去势诱导的慢性非细菌性前列腺炎(chronic nonbacterial prostatitis,CNBP)大鼠前列腺中嗜铬粒蛋白A(chromogranin A,CgA)和神经元特异性烯醇化酶(neuron-specic enolase,NSE)水平变化,以评价神经内... 目的本研究旨在测定17-β-雌二醇联合去势诱导的慢性非细菌性前列腺炎(chronic nonbacterial prostatitis,CNBP)大鼠前列腺中嗜铬粒蛋白A(chromogranin A,CgA)和神经元特异性烯醇化酶(neuron-specic enolase,NSE)水平变化,以评价神经内分泌细胞在CNBP发病机制中的作用。方法将72只SD大鼠随机分为溶剂对照组(Con)组、生理盐水(NS)组、假手术(Sham)组、手术去势(Sca)组、17-β雌二醇(17-βEst)组、去势+17-βEst组(Sca+17-βEst),每组12只。根据分组进行处理,30 d后,收集各组大鼠前列腺组织,采用HE染色、ELISA、RT-qPCR、Western blot和免疫组织化学等技术检测各组组织病理变化、炎症因子水平以及CgA和NSE表达的变化。结果HE染色显示,Con组、NS组和Sham组的腺上皮和间质外观正常,Sca组和17-βEst组没有发现明显的炎性病变。相比上述5组,Sca+17-βEst组腺基质中的上皮发生变性,炎性细胞于间质间隙广泛浸润,偶而出现在导管腔内。与Con组相比,Sca+17-βEst组大鼠前列腺中CgA和NSE的m RNA和蛋白表达明显增加。另外,ELISA结果显示,相比于其他5组,Sca+17-βEst组的血清CgA和NSE浓度显著升高。CgA和NSE阳性染色在Con组、NS组和Sham组前列腺的细胞膜和细胞质中呈弱阳性表达;在Sca组和17-βEst组这些亚细胞部位呈轻度增强。与其他各组相比,Sca+17-βEst组CgA和NSE阳性染色在细胞质和细胞膜上呈强阳性表达。结论17-β雌二醇联合去势可能通过上调CgA与NSE的表达诱导慢性非细菌性前列腺炎。 展开更多
关键词 慢性非细菌性前列腺炎 嗜铬粒蛋白A 神经元特异性烯醇化酶 17-Β雌二醇
暂未订购
健脾养肝丸调控肠嗜铬细胞及其TPH1-5-HT信号通路治疗IBS-D大鼠的机制研究
19
作者 朱婷 陈欣 +6 位作者 赵鑫 胡雪婷 谢祥 栾云鹏 李襄 王华宁 马可 《天津中医药》 2025年第9期1192-1201,共10页
[目的]通过研究健脾养肝丸对腹泻型肠易激综合征(IBS-D)模型大鼠嗜铬细胞/5-羟色胺(EC/5-HT)信号通路表达的影响,进一步探索健脾养肝丸是否通过调节嗜铬细胞(EC)中5-羟色胺(5-HT)的分泌来缓解IBS-D的内脏高敏感(VH),从而揭示其治疗IBS-... [目的]通过研究健脾养肝丸对腹泻型肠易激综合征(IBS-D)模型大鼠嗜铬细胞/5-羟色胺(EC/5-HT)信号通路表达的影响,进一步探索健脾养肝丸是否通过调节嗜铬细胞(EC)中5-羟色胺(5-HT)的分泌来缓解IBS-D的内脏高敏感(VH),从而揭示其治疗IBS-D的内脏敏感机制。[方法]采用母婴分离结合束缚应激法制备IBS-D大鼠模型,通过粪便评分、粪便含水率测定、腹泻指数检测及内脏敏感性测定法评价IBS-D模型及健脾养肝丸的疗效;采用酶联免疫吸附(ELISA)实验、实时荧光定量聚合酶链反应(qPCR)实验、免疫组化染色、免疫荧光染色及电镜检测EC中5-HT的合成、分泌情况。[结果]与模型组相比,健脾养肝丸高、中、低剂量组降低了IBS-D大鼠Bristol粪便性状评分、粪便含水量、内脏敏感性、结肠及血清5-HT水平、TPH1的mRNA相对表达量(P<0.05或<0.01),减轻了结肠组织病理损伤,减少了嗜铬粒蛋白A(CgA)阳性表达,且通过健脾养肝丸的治疗,EC呈现椭圆形、分泌颗粒减少。[结论]健脾养肝丸可能通过降低TPH1介导EC重摄取色氨酸分解成为5-羟色胺酸(5-HTP),进而减少5-HT的生成从而降低内脏高敏感。 展开更多
关键词 腹泻型肠易激综合征 内脏高敏感 健脾养肝丸 嗜铬细胞 5-羟色胺 嗜铬粒蛋白A
暂未订购
Gas6、CgA、LP-PLA2对冠脉造影介入术后发生MACE预测价值
20
作者 吴连君 《航空航天医学杂志》 2025年第8期902-905,共4页
目的探究生长停滞特异性蛋白6(Gas6)、嗜铬粒蛋白A(CgA)、脂蛋白相关磷脂酶A2(LP-PLA2)对冠状动脉(简称“冠脉”)造影介入术后发生主要不良心血管事件(MACE)预测价值。方法回顾性分析2022年10月~2024年10月在本院行冠脉造影介入术的162... 目的探究生长停滞特异性蛋白6(Gas6)、嗜铬粒蛋白A(CgA)、脂蛋白相关磷脂酶A2(LP-PLA2)对冠状动脉(简称“冠脉”)造影介入术后发生主要不良心血管事件(MACE)预测价值。方法回顾性分析2022年10月~2024年10月在本院行冠脉造影介入术的162例冠心病患者临床资料,按术后1年内MACE发生情况将患者分为30例发生组与132例未发生组。检测两组入院后Gas6、CgA、LP-PLA2水平,采用多元线性回归分析影响患者冠脉造影介入术后发生MACE的因素,采用受试者工作特征(ROC)曲线分析Gas6、CgA、LP-PLA2对患者冠脉造影介入术后发生MACE预测价值。结果发生组年龄比未发生组高,病变支数比未发生组多(P<0.05)。发生组Gas6水平比未发生组低,CgA、LP-PLA2水平比未发生组高(P<0.05)。多元线性回归分析结果显示,年龄、病变支数、Gas6、CgA、LP-PLA2均为冠心病患者冠脉造影介入术后发生MACE的影响因素(P<0.05)。ROC曲线分析结果显示,Gas6、CgA、LP-PLA2单一及联合检测预测冠脉造影介入术后发生MACE的AUC(95%CI)分别为0.763(0.690~0.826)、0.811(0.743~0.869)、0.787(0.715~0.847)、0.896(0.838~0.938)。结论Gas6、CgA、LP-PLA2对冠脉造影介入术后发生MACE的预测价值较高,值得临床推广应用。 展开更多
关键词 冠心病 经皮冠状动脉介入术 不良心血管事件 生长停滞特异性蛋白6 嗜铬粒蛋白A 脂蛋白相关磷脂酶A2
暂未订购
上一页 1 2 12 下一页 到第
使用帮助 返回顶部